ChromaDex Corporation (CDXC)
NASDAQ: CDXC · Real-Time Price · USD
5.98
+0.06 (1.01%)
Jan 23, 2025, 4:00 PM EST - Market closed
ChromaDex Employees
ChromaDex had 106 employees as of December 31, 2023. The number of employees decreased by 7 or -6.19% compared to the previous year.
Employees
106
Change (1Y)
-7
Growth (1Y)
-6.19%
Revenue / Employee
$864,792
Profits / Employee
$14,009
Market Cap
457.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Walmart | 2,100,000 |
| PepsiCo | 318,000 |
| Costco Wholesale | 316,000 |
| Anheuser-Busch InBev | 154,450 |
| Unilever | 128,000 |
| The Procter & Gamble Company | 107,000 |
| Mondelez International | 91,000 |
| Philip Morris International | 82,700 |
CDXC News
- 17 days ago - ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire
- 7 weeks ago - ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - Business Wire
- 2 months ago - ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement - Business Wire
- 2 months ago - ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide - Business Wire
- 2 months ago - ChromaDex Corporation (CDXC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ChromaDex Corporation Reports Third Quarter 2024 Financial Results - Business Wire
- 3 months ago - ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 - Business Wire
- 3 months ago - ChromaDex to Participate in the 17th Annual LD Micro Main Event - Business Wire